Conference abstractPublished 20 Sep 2018
Targeting NMDA Subtype glutamate in brain diseases
Peking University, China
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
NMDA subtype glutamate receptors play critical roles in the refinement of neural connections during development and learning and memory functions in the adult. Their excessive activation is also believed to have critical contributions to neuronal death under pathological/neurodegenerative conditions, while hypofunction is propsoed to undelie the oncogenesis of certain psychiatric diseases. In this talk, I will discuss our recent efforts in enhancing NMDAR function for treating psychiatric diseases (such as schizophrenia) and inhibiting their activation in treating neurodegenerative diseases (such as Alzheimer’s). For the former approach, we have screened large amount of compounds and identified a few series of positive allosteric modulators (PAMs), and I will discuss their mode of action (such as GluN2A selectivity) and unique and interesting properties. For the latter, I will discuss our evaluation of GluN2B-selective antagonists in Alzheimer’s disease model mice and their therapeutic potentials. I will also briefly discuss the pros and cons of trageting NMDARs in treating brain diseases.
Subjects
Neuroscience & NeurologyAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- SubjectNeuroscience & Neurology
- BylineArticles whose byline prints “Qiang Zhou”
